Roche asks court for halt of Novartis unit’s generic launch

04-04-2022

Roche asks court for halt of Novartis unit’s generic launch

Michael Vi / Shutterstock.com

Roche’s subsidiary Genentech has asked a Delaware court to block two of Novartis’ units from selling a generic version of the blockbuster lung-disease drug Esbriet (pirfenidone).


Roche, Genentech, Intermune, Novartis, Sandoz, Lek Pharmaceuticals, generics, ANDA, Esbriet, injunction

LSIPR